Clinical Trials Logo
  1. Home
  2. Renal Transplant Recipients
  3. NCT03110406

Effects of Whole-body Vibration Training on the Heart Rate Variability Cardiac in Kidney Transplantation

Renal Transplant Recipients Clinical Trial

Official title:
Effects of Whole-body Vibration Training on the Heart Rate Variability Cardiac in Kidney Transplantation: a Randomized Controlled Trial

Clinical Trial Summary

Introduction: Renal transplantation represents the therapeutic mode with more durable treatment, greater cost-effectiveness, survival benefits and quality of life of the patients, however, with high cardiovascular mortality.

Objectives: To evaluate the acute and chronic effects on heart rate variability and the impact of chronic kidney disease on cardiorespiratory fitness in renal transplant recipients following a full-body Vibration training program.

Methods: It will be a blinded randomized clinical trial (patient, evaluator and statistician), controlled and endowed with secrecy of allocation, to be performed in the Cardiopulmonary Physiotherapy Laboratory of the Physiotherapy Department of the Federal University of Pernambuco. Renal transplant recipients will be recruited at the Nephrology outpatient clinic of the Hospital das Clínicas de Pernambuco, according to the following inclusion criteria: age between 18 and 59 years, who underwent transplantation at least one year before and present a stable transplant function through the level Of creatinine

Clinical Trial Description

It will be a blinded randomized clinical trial (patient, evaluator and statistician), controlled and endowed with secrecy of allocation, to be performed in the Cardiopulmonary Physiotherapy Laboratory of the Physiotherapy Department of the Federal University of Pernambuco. Renal transplant recipients will be recruited at the Nephrology outpatient clinic of the Hospital das Clínicas de Pernambuco, according to the inclusion criteria ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03110406
Study type Interventional
Source Universidade Federal de Pernambuco
Contact TUIRA O MAIA
Phone 81997160176
Email tuiraomaia@gmail.com
Status Recruiting
Phase N/A
Start date March 10, 2017
Completion date March 10, 2018
View Details
See also
  Status Clinical Trial Phase
Terminated NCT02956005 - Envarsus XR in African American Renal Transplant Recipients N/A
Completed NCT01086904 - Safety and Efficacy of an Inactivated and Non Adjuvanted Vaccine Against Influenza A in Renal Transplant Recipients Phase 2
Completed NCT00319189 - Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients Phase 4
Completed NCT01859832 - Validation of a Novel Diagnostic Tool for the Evaluation of Post Renal Transplant Immunosuppression: The ImmuKnow Assay N/A
Recruiting NCT02973464 - The Strategy in the Prevention of Renal Post-transplant Cytomegalovirus Infection Among Chinese Population Phase 3
Active, not recruiting NCT03797196 - RCT Comparing Immunosuppressive Regimens in Elderly Renal Transplant Recipients Phase 4
Terminated NCT01318915 - Research Study of ATG and Rituximab in Renal Transplantation Early Phase 1
Recruiting NCT00327483 - Web Based Renal Transplant Patient Medication Education Phase 4
Terminated NCT00271830 - Sexual Function in Male Renal Transplant Patients N/A
Completed NCT00138970 - Calcineurin Inhibitor-Free Immunosuppression in Renal Transplant Recipients at Low Immunogenic Risk Phase 4
Withdrawn NCT04903054 - Selective CD28 Blockade in Renal Transplant Recipients Phase 2
Completed NCT02706678 - Efficacy and Safety Study of the Switch From Cyclosporin to Tacrolimus in Renal Transplant Recipients Phase 4
Active, not recruiting NCT04218721 - Implementing eHealth Interventions Into Regular Clinical Practice N/A
Recruiting NCT03726307 - Allogeneic Regulatory Dendritic Cell (DCreg) Renal Study Phase 1